September 2019 Issue Table Of Contents
Source: Life Science Leader

From The Editor
Feature Article
- The Story Of Pfizer’s R&D Turnaround
- What’s Necessary To Realize The Promise Of Digital Health Solutions?
Capitol Perspectives
CEO Corner
From Principles and Policy to Execution
Companies To Watch
Industry Research
Inside The Industry
- Patient Diversity Starts With Community Connections
- Athira’s Whole-Patient Drug Development
- Comparative Biosimilar Clinical Trials: More Questions Than Answers?
- Culturing The Culture
- Jeremy Levin Weighs In On Biosimilar Patent Thicket
Leadership Lessons
Ask The Board
- What Are The Critical Components Necessary When Attempting To Attract An Angel Investor To Your Biopharmaceutical Startup?
- What Should Be Done By Engineers Toward Developing New Methods And Approaches For Process Development And Facility Design To Make The Wide Range Of New Products Faster And Cheaper?
- What Are The Critical Components Necessary When Attempting To Attract An Angel Investor To Your Biopharma Startup?
This website uses cookies to ensure you get the best experience on our website. Learn more